<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Endocrinology</journal-id>
<journal-id journal-id-type="iso-abbrev">Endocrinology</journal-id>
<journal-id journal-id-type="publisher-id">endo</journal-id>
<journal-title-group>
<journal-title>Endocrinology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0013-7227</issn>
<issn pub-type="epub">1945-7170</issn>
<publisher>
<publisher-name>Endocrine Society</publisher-name>
<publisher-loc>Washington, DC</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31199479</article-id>
<article-id pub-id-type="pmc">6660906</article-id>
<article-id pub-id-type="publisher-id">201900107</article-id>
<article-id pub-id-type="doi">10.1210/en.2019-00107</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
<subj-group subj-group-type="category-toc-heading">
<subject>Signaling Pathways</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>USP8 Deubiquitinates the Leptin Receptor and Is Necessary for Leptin-Mediated Synapse Formation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bland</surname>
<given-names>Tyler</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sahin</surname>
<given-names>Gulcan Semra</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Mingyan</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dillon</surname>
<given-names>Crystal</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Impey</surname>
<given-names>Soren</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Appleyard</surname>
<given-names>Suzanne M</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-8439-3504</contrib-id>
<name>
<surname>Wayman</surname>
<given-names>Gary A</given-names>
</name>
<!--<email>waymang@wsu.edu</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="c1"></xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Department of Integrated Physiology and Neuroscience, Washington State University, Pullman, Washington</aff>
<aff id="aff2"><label>2</label>Oregon Stem Cell Center, Oregon Health and Sciences University, Portland, Oregon</aff>
<author-notes>
<corresp id="c1"><bold><italic>Correspondence:</italic></bold> Gary A. Wayman, PhD, Department of Integrative Physiology and Neuroscience, Program in Neuroscience, Washington State University, Pullman, Washington 99164. E-mail: <email>waymang@wsu.edu</email>.</corresp>
</author-notes>
<pub-date pub-type="collection">
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2019-06-14" pub-type="epub">
<day>14</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>14</day>
<month>6</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
<volume>160</volume>
<issue>8</issue>
<fpage>1982</fpage>
<lpage>1998</lpage>
<history>
<date date-type="received">
<day>08</day>
<month>2</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>6</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Endocrine Society</copyright-statement>
<copyright-year>2019</copyright-year>
</permissions>
<self-uri xlink:href="en.2019-00107.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Leptin has neurotrophic actions in the hippocampus to increase synapse formation and stimulate neuronal plasticity. Leptin also enhances cognition and has antidepressive and anxiolytic-like effects, two hippocampal-dependent behaviors. In contrast, mice lacking leptin or the long form of the leptin receptor (LepRb) have lower cortical volume and decreased memory and exhibit depressive-like behaviors. A number of the signaling pathways regulated by LepRb are known, but how membrane LepRb levels are regulated in the central nervous system is not well understood. Here, we show that the lysosomal inhibitor chloroquine increases LepRb expression in hippocampal cultures, suggesting that LepRb is degraded in the lysosome. Furthermore, we show that leptin increases surface expression of its own receptor by decreasing the level of ubiquitinated LepRbs. This decrease is mediated by the deubiquitinase ubiquitin-specific protease 8 (USP8), which we show is in complex with LepRb. Acute leptin stimulation increases USP8 activity. Moreover, leptin stimulates <italic>USP8</italic> gene expression through cAMP response element–binding protein (CREB)–dependent transcription, an effect blocked by expression of a dominant-negative CREB or with short hairpin RNA knockdown of CREB. Increased expression of USP8 causes increased surface localization of LepRb, which in turn enhances leptin-mediated activation of the MAPK kinase/extracellular signal–regulated kinase pathway and CREB activation. Lastly, increased USP8 expression increases glutamatergic synapse formation in hippocampal cultures, an effect dependent on expression of LepRbs. Leptin-stimulated synapse formation also requires USP8. In conclusion, we show that USP8 deubiquitinates LepRb, thus inhibiting lysosomal degradation and enhancing surface localization of LepRb, which are essential for leptin-stimulated synaptogenesis in the hippocampus.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Mental Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000025</named-content>
</funding-source>
<award-id>MH086032</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Child Health and Human Development</named-content>
<named-content content-type="funder-identifier">10.13039/100000071</named-content>
</funding-source>
<award-id>HD092369</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="17"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>